Community Health Systems (CYH) Q3 2024 earnings summary

Executive summary

• Net operating revenues for Q3 2024 were $3.09 billion, up 0.1% year-over-year; same-store revenues rose 5.1% due to higher volumes, reimbursement rates, and favorable payor mix, offset by divestitures.

• Net loss attributable to stockholders was $391 million, or $(2.95) per share, compared to $91 million in Q3 2023, driven by significant impairment charges, professional liability accruals, and hurricane impacts.

• Adjusted EBITDA for Q3 2024 was $347 million, down from $360 million in Q3 2023; margin declined to 11.2%.

• Same-store admissions and adjusted admissions increased 2.4% and 2.6% year-over-year, while consolidated admissions declined due to divestitures.

• Strategic investments in facility expansions and urgent care acquisitions, along with divestitures, are fueling volume growth and market share gains.

Financial highlights

• Nine-month net operating revenues were $9.369 billion, up 0.7% year-over-year; same-store revenues up 5.2%.

• Nine-month net loss attributable to stockholders was $446 million, or $(3.38) per share, compared to $180 million, or $(1.38) per share, in 2023.

• Nine-month adjusted EBITDA was $1.112 billion, up from $1.068 billion in 2023.

• Net cash from operating activities for nine months was $264 million, up from $120 million in 2023.

• Q3 2024 operating expenses rose to 106.6% of revenues, mainly due to impairment and liability accruals.

Outlook and guidance

• 2024 net operating revenues projected at $12.45–$12.55 billion; adjusted EBITDA guidance is $1.5–$1.54 billion.

• 2024 net loss per diluted share expected between $(0.60) and $(0.50).

• Capital expenditures for 2024 projected at $350–$400 million, including hurricane remediation costs.

• Net cash from operating activities for 2024 projected at $400–$500 million.

• Proceeds from divestitures expected to be used for debt repayment, repurchases, and capital expenditures.